Patents by Inventor Frank S. Menniti

Frank S. Menniti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20010007872
    Abstract: This invention relates to a method of treating acute, chronic and/or neuropathic pain in which a mammal suffering from acute, chronic and/or neuropathic pain is treated with an effective amount of an NR2B selective NMDA antagonist having a ratio of NR2B receptor activity to &agr;1-adrenergic receptor activity of at least about 3:1.
    Type: Application
    Filed: September 17, 1999
    Publication date: July 12, 2001
  • Patent number: 6258827
    Abstract: This invention relates to a method of treating Parkinson's Disease whereby a mammal suffering from Parkinson's Disease is treated with a combination of a forebrain selective NMDA antagonist and a compound which is capable of increasing the excitatory feedback from the ventral lateral nucleus of the thalamus into the cortex. This invention also relates to pharmaceutical compositions containing the synergistic combination.
    Type: Grant
    Filed: October 10, 1997
    Date of Patent: July 10, 2001
    Assignee: Pfizer Inc.
    Inventors: Bertrand L. Chenard, Frank S. Menniti
  • Patent number: 6136812
    Abstract: The invention relates to a method of treating dyskinesias associated with dopamine agonist therapy in a mammal which comprises administering to said mammal a compound, as defined herein, which is an antagonist of the AMPA receptor. Dopamine agonist therapy, as referred to in the present invention, is generally used in the treatment of a central nervous system disorder such as Parkinson's disease.
    Type: Grant
    Filed: September 4, 1998
    Date of Patent: October 24, 2000
    Assignee: Pfizer Inc
    Inventors: Bertrand L. Chenard, Willard M. Welch, Frank S. Menniti